FEDERATED HERMES, INC. - NEOLEUKIN THERAPEUTICS INC ownership

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,291
-3.1%
1,555
-18.3%
0.00%
Q1 2023$1,332
-41.9%
1,903
-57.8%
0.00%
Q4 2022$2,294
-23.5%
4,507
+4.8%
0.00%
Q3 2022$3,000
-25.0%
4,300
+2.0%
0.00%
Q2 2022$4,0000.0%4,215
+78.6%
0.00%
Q1 2022$4,000
-96.8%
2,360
-90.8%
0.00%
Q4 2021$124,00025,7470.00%
Other shareholders
NEOLEUKIN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,386,300$19,547,0002.55%
EcoR1 Capital, LLC 3,122,704$44,030,0002.37%
Redmile Group, LLC 4,131,869$58,259,0000.70%
Boxer Capital, LLC 1,501,058$21,165,0000.68%
HighVista Strategies LLC 69,727$983,0000.63%
Baker Brothers Advisors 3,821,740$53,887,0000.20%
Highland Private Wealth Management 93,998$1,326,0000.12%
Sio Capital Management, LLC 38,312$540,0000.11%
Point72 Asset Management, L.P. 1,195,725$16,860,0000.08%
Granahan Investment Management 246,299$3,473,0000.08%
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders